These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1732363)
21. Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart. Shenasa M; Denker S; Mahmud R; Lehmann M; Estrada A; Akhtar M J Am Coll Cardiol; 1984 Jul; 4(1):105-10. PubMed ID: 6736436 [TBL] [Abstract][Full Text] [Related]
22. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. Feld GK; Venkatesh N; Singh BN Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774 [TBL] [Abstract][Full Text] [Related]
23. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727 [TBL] [Abstract][Full Text] [Related]
24. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Kadish AH; Marchlinski FE; Josephson ME; Buxton AE Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759 [TBL] [Abstract][Full Text] [Related]
25. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans. Newman D; Dorian P; Feder-Elituv R Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233 [TBL] [Abstract][Full Text] [Related]
27. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease. Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121 [TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia. Gold RL; Haffajee CI; Alpert JS Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294 [TBL] [Abstract][Full Text] [Related]
29. Electrocardiographic body surface mapping in patients with ventricular tachycardia. Assessment of utility in the identification of effective pharmacological therapy. Mitchell LB; Hubley-Kozey CL; Smith ER; Wyse DG; Duff HJ; Gillis AM; Horacek BM Circulation; 1992 Aug; 86(2):383-93. PubMed ID: 1638707 [TBL] [Abstract][Full Text] [Related]
30. Evaluation by serial electrophysiologic studies of an abbreviated oral loading regimen of amiodarone. Kennedy EE; Rosenfeld LE; McPherson CA; Batsford WP Am J Cardiol; 1985 Nov; 56(13):867-71. PubMed ID: 3904386 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM; Lee JT; Woosley RL; Echt DS Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262 [TBL] [Abstract][Full Text] [Related]
32. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. Fananapazir L; Epstein SE Am J Cardiol; 1991 Jan; 67(2):175-82. PubMed ID: 1987719 [TBL] [Abstract][Full Text] [Related]
34. Effect of pacing drive cycle length on induction of sustained monomorphic ventricular tachycardia. Mann DE; Florek RC; Reiter MJ J Electrocardiol; 1992 Jan; 25(1):33-8. PubMed ID: 1735790 [TBL] [Abstract][Full Text] [Related]
35. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans. Duff HJ; Mitchell LB; Manyari D; Wyse DG J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109 [TBL] [Abstract][Full Text] [Related]
36. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics. Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187 [TBL] [Abstract][Full Text] [Related]
37. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479 [TBL] [Abstract][Full Text] [Related]